AMLODIPINE AND ATORVASTATIN
Generic: AMLODIPINE AND ATORVASTATIN
Apotex Corp.Manufacturer
ORALRoute
AMLODIPINE BESYLATEActive Substance
2019-11-18Original Approval
AMLODIPINE AND ATORVASTATIN is FDA application ANDA205199, sponsored by APOTEX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
35 reports
2
DIARRHOEA
30 reports
3
DEATH
27 reports
4
DYSPNOEA
24 reports
5
COUGH
23 reports
6
DIZZINESS
20 reports
7
PNEUMONIA
20 reports
8
NAUSEA
18 reports
9
ASTHENIA
17 reports
10
HEADACHE
17 reports